Objective:To assess the best suitable condition for virus inactivation.and to study the immunogenic potential and protective efficacy of a circulating West Nile virus(WNV) strain in Assam.Methods:Bulk preparation of c...Objective:To assess the best suitable condition for virus inactivation.and to study the immunogenic potential and protective efficacy of a circulating West Nile virus(WNV) strain in Assam.Methods:Bulk preparation of circulating WNV:WNIRGC07(GeneBank ID:HQ246154).was undertaken in a bioreaclor using eytodex-1.Virus Inactivation was done in three different conditions:22 ℃.4 ℃ and room temperature.The virus preparations were evaluated for antigenicity by ELISA and toxicity by cell proliferation kit.Virus efficacy was done in-viro on swiss albino mice against standard Indian WNV and Japanese encephalitis virus(JKV)strain.Humoral and cell mediated immune response was evaluated in mice sera by ELISA and neutralization assay.Results:Inactivation at 22 ℃ was found to be more suitable in terms of less toxicity and high antigenicity.The same was selected to study the immune response and efficacy in mice.It induced neutralizing antibody titre of 1:625 and high EgG response.In vivo experiment showed 100% protective efficacy against WNV and 20.8% cross protective efficacy against JEV.Further assessment of cellular immunity through immunized mice revealed augmentation of high levels of pro-inflammatory cytokines and moderate levels of anti—cytokines indicating a mixed balance of Th1 and Th2 response.Conclusions:Findings suggest that formalin inactivated Indian WNV strain has a good immunogenic potential.This is the first study on assessment of immunogenic potential of a lineage 5 strain of WNV.Our study reveals that it would be a promising and effective candidate for vaccine studies which warrants further evaluation.展开更多
The need for an efficacious HIV/AIDS vaccine remains the highest priority of the world HIV/AIDS agenda. The generation of an efficacious HIV/AIDS vaccine proves an enormous scientific challenge. This article reviews t...The need for an efficacious HIV/AIDS vaccine remains the highest priority of the world HIV/AIDS agenda. The generation of an efficacious HIV/AIDS vaccine proves an enormous scientific challenge. This article reviews the neutralizing antibody problem,elusive immune protection,im-munogen design,pre-existing anti-vector immunity and design of phase 3 vaccine trials and the challenges and opportunities in development of HIV/AIDS vaccine are discussed.展开更多
文摘Objective:To assess the best suitable condition for virus inactivation.and to study the immunogenic potential and protective efficacy of a circulating West Nile virus(WNV) strain in Assam.Methods:Bulk preparation of circulating WNV:WNIRGC07(GeneBank ID:HQ246154).was undertaken in a bioreaclor using eytodex-1.Virus Inactivation was done in three different conditions:22 ℃.4 ℃ and room temperature.The virus preparations were evaluated for antigenicity by ELISA and toxicity by cell proliferation kit.Virus efficacy was done in-viro on swiss albino mice against standard Indian WNV and Japanese encephalitis virus(JKV)strain.Humoral and cell mediated immune response was evaluated in mice sera by ELISA and neutralization assay.Results:Inactivation at 22 ℃ was found to be more suitable in terms of less toxicity and high antigenicity.The same was selected to study the immune response and efficacy in mice.It induced neutralizing antibody titre of 1:625 and high EgG response.In vivo experiment showed 100% protective efficacy against WNV and 20.8% cross protective efficacy against JEV.Further assessment of cellular immunity through immunized mice revealed augmentation of high levels of pro-inflammatory cytokines and moderate levels of anti—cytokines indicating a mixed balance of Th1 and Th2 response.Conclusions:Findings suggest that formalin inactivated Indian WNV strain has a good immunogenic potential.This is the first study on assessment of immunogenic potential of a lineage 5 strain of WNV.Our study reveals that it would be a promising and effective candidate for vaccine studies which warrants further evaluation.
基金National High Technology Research and Development Program of China(2005AAZ18040)
文摘The need for an efficacious HIV/AIDS vaccine remains the highest priority of the world HIV/AIDS agenda. The generation of an efficacious HIV/AIDS vaccine proves an enormous scientific challenge. This article reviews the neutralizing antibody problem,elusive immune protection,im-munogen design,pre-existing anti-vector immunity and design of phase 3 vaccine trials and the challenges and opportunities in development of HIV/AIDS vaccine are discussed.
